Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippa Easterbrook

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Haematologica|April 2, 2009
CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UKMark Bower, Martin Fisher, Teresa Hill, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHOAdelina Artenie, Niklas Luhmann, Aaron G Lim, et al.
European Journal of Neurology|December 17, 2010
HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era, Lucy Garvey, Alan Winston, et al.
AIDS (London, England)|September 23, 2009
Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?Alison D Grant, Loveleen Bansi, Jonathan Ainsworth, et al.
The Journal of Infectious Diseases|January 27, 2012
Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy?Mark Gompels, David T Dunn, Andrew Phillips, et al.
African Journal of Laboratory Medicine|March 6, 2023
Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from UgandaDenis Omali, Allan Buzibye, Richard Kwizera, et al.
The Journal of Experimental Medicine|December 15, 2004
HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptorTao Dong, Guillaume Stewart-Jones, Nan Chen, et al.
AIDS (London, England)|March 15, 2005
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practiceAndrew N Phillips, David Dunn, Caroline Sabin, et al.
AIDS (London, England)|January 16, 2008
Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?Loveleen K Bansi, Andrew A Benzie, Andrew N Phillips, et al.
BMC Infectious Diseases|November 17, 2017
The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testingJoseph D Tucker, Kathrine Meyers, John Best, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Haematologica|April 2, 2009
CD4 counts and the risk of systemic non-Hodgkin's lymphoma in individuals with HIV in the UKMark Bower, Martin Fisher, Teresa Hill, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHOAdelina Artenie, Niklas Luhmann, Aaron G Lim, et al.
European Journal of Neurology|December 17, 2010
HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era, Lucy Garvey, Alan Winston, et al.
AIDS (London, England)|September 23, 2009
Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?Alison D Grant, Loveleen Bansi, Jonathan Ainsworth, et al.
The Journal of Infectious Diseases|January 27, 2012
Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy?Mark Gompels, David T Dunn, Andrew Phillips, et al.
African Journal of Laboratory Medicine|March 6, 2023
Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from UgandaDenis Omali, Allan Buzibye, Richard Kwizera, et al.
The Journal of Experimental Medicine|December 15, 2004
HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptorTao Dong, Guillaume Stewart-Jones, Nan Chen, et al.
AIDS (London, England)|March 15, 2005
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practiceAndrew N Phillips, David Dunn, Caroline Sabin, et al.
AIDS (London, England)|January 16, 2008
Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?Loveleen K Bansi, Andrew A Benzie, Andrew N Phillips, et al.
BMC Infectious Diseases|November 17, 2017
The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testingJoseph D Tucker, Kathrine Meyers, John Best, et al.
Pageof 15